SOCS1 and stroke disorder: In one study, injection of an miR-155 inhibitor (anti-miR-155 miRCURY LNATM, Product# 4101082-001, Exiqon) in stroke-induced mice showed significant decrease in cytokines profiles that were correlated with increased expression of miR-155 targets SOCS1 and SHIP1 (Figure 4B) [146].